Direct and Indirect Antiglobulin (Coombs) Tests

The antiglobulin test, commonly called the Coombs test, uses an antihuman globulin reagent to detect immunoglobulin or complement bound to red cells. Its direct form reveals antibody already coating a patient's red cells in vivo, while its indirect form detects antibody in plasma that binds reagent cells in vitro; together they are central tools of immunohematology.

Definition

The antiglobulin (Coombs) test detects human immunoglobulin or complement components on red cells using an antihuman globulin reagent that crosslinks coated cells into visible agglutinates; the direct test examines the patient's own red cells, and the indirect test examines reagent red cells after incubation with the patient's plasma.

Scope

This topic explains the principle of the antiglobulin reaction and the distinction between the direct antiglobulin test (DAT) and the indirect antiglobulin test (IAT), and where each fits in serological work-up. It describes the test method and interpretation conceptually and is not a protocol for diagnosing or managing specific patients.

Core questions

• How does antihuman globulin reagent make antibody-coated cells agglutinate?
• What distinguishes the direct from the indirect antiglobulin test?
• What does a positive direct antiglobulin test indicate?
• How is the indirect antiglobulin test used in antibody detection and crossmatching?

Key concepts

• Antihuman globulin (AHG) reagent
• Incomplete (IgG) antibodies
• Direct antiglobulin test (DAT)
• Indirect antiglobulin test (IAT)
• In vivo versus in vitro sensitisation
• Polyspecific and monospecific reagents (IgG, C3)
• Agglutination as the read-out

Mechanisms

Many clinically important red-cell antibodies are IgG and do not directly agglutinate antigen-positive cells in saline because the molecules are too small to bridge cells repelled by their surface charge. Antihuman globulin reagent, raised against human IgG and complement, binds these coating molecules and bridges adjacent sensitised cells, producing visible agglutination. In the direct test, washed red cells from the patient are mixed with reagent to detect antibody or complement already bound in vivo, as occurs in haemolytic transfusion reactions, haemolytic disease of the newborn, and autoimmune haemolytic anaemia. In the indirect test, plasma is first incubated with reagent red cells so that any antibody binds in vitro, then antiglobulin reagent is added; this underlies antibody screening, identification, and the antiglobulin crossmatch.

Clinical relevance

Antiglobulin testing supports the laboratory investigation of haemolysis and the safe selection of blood components. This entry describes how the test works and what positive and negative results indicate in principle; the interpretation of any individual result belongs to the clinical and laboratory context and is not addressed here as guidance.

Evidence & guidelines

The antiglobulin technique and its variants are described in standard immunohematology references such as the AABB Technical Manual and Mollison's Blood Transfusion in Clinical Medicine, which set out method and interpretation by consensus.

History

Coombs, Mourant, and Race introduced the antiglobulin test in 1945 to detect weak and incomplete Rh antibodies that ordinary saline agglutination missed. The technique transformed immunohematology by making IgG sensitisation visible, and it remains the basis of antibody screening, identification, crossmatching, and the investigation of immune haemolysis.

Key figures

• Robert Coombs
• Arthur Mourant
• Robert Race

Seminal works

• coombs-1945
• mollison-2014
• daniels-2013

Frequently asked questions

What is the difference between the direct and indirect Coombs test?

The direct test detects antibody or complement already bound to a patient's red cells in the body; the indirect test detects antibody in plasma by binding it to reagent red cells in the test tube before adding antiglobulin reagent.

What can cause a positive direct antiglobulin test?

A positive direct antiglobulin test indicates red cells are coated with immunoglobulin or complement, which can occur in autoimmune haemolytic anaemia, haemolytic disease of the newborn, and haemolytic transfusion reactions, among other settings.